Physician profile
Amy Samples
NPI 1376816587
$2,291.74
in general payments reported to CMS, 2019-2025
10 companies · $84.49 in 2025
The $84.49 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $436 · 2022: $421 · 2023: $864 · 2024: $487 · 2025: $84.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,435.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $584.54 | 2021-2024 | Jardiance, Synjardy, Tradjenta |
| Dexcom, INC. | $495.88 | 2021-2024 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals Lp | $400.08 | 2021-2023 | Farxiga |
| Lilly USA, LLC | $369.15 | 2023-2025 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $149.98 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $100.59 | 2023 | |
| Novo Nordisk INC | $89.45 | 2021-2024 | Ozempic, Rybelsus |
| Medtronic, INC. | $72.96 | 2021-2024 | Minimed 780g |
| Xeris Pharmaceuticals, INC. | $15.50 | 2024 | Gvoke Hypopen |
| Insulet Corporation | $13.61 | 2025 | Omnipod |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Samples listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.